cyanopindolol has been researched along with Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cazaux, C; Cremaschi, GA; Miguel, S; Sterin-Borda, L | 1 |
| Levitzki, A; Marbach, I; Shiloach, J | 1 |
2 other study(ies) available for cyanopindolol and Lymphoma
| Article | Year |
|---|---|
Increased proliferative activity, loss of beta-adrenergic receptor function and class I major histocompatibility complex antigen surface expression in a modified lymphoma cell line.
Topics: Adrenergic beta-Antagonists; Animals; Biomarkers; Cell Division; Histocompatibility Antigens Class I; Lymphoma; Mice; Pindolol; Receptors, Adrenergic, beta; Tumor Cells, Cultured | 1994 |
Gi affects the agonist-binding properties of beta-adrenoceptors in the presence of Gs.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Catalysis; Cholera Toxin; Erythrocyte Membrane; GTP-Binding Proteins; Isoproterenol; Lymphoma; Pertussis Toxin; Pindolol; Receptors, Adrenergic, beta; Turkeys; Virulence Factors, Bordetella | 1988 |